Q: there's some fringe companies doing experiments with magic mushrooms to treat anxiety, depression and a number of other ailments. If this takes off do you think this could have lots of upside , or will this be attacked by large drug makers whose patented drugs could loose market share ? Thanks alot.
-
Indiva Limited (NDVA)
-
Vext Science Inc. (VEXT)
-
Mind Medicine Inc (Sub Voting) (MMEDF)
-
Wishpond Technologies Ltd. (WISH)
-
Tilray Brands Inc. (TLRY)
-
Robinhood Markets Inc. (HOOD)
-
Voyager Digital Ltd. (VOYG)
Q: These 7 losers are a 3% drain on my otherwise successful portfolio. They currently make up about 3% of portfolio total. Are any worth keeping for med to long term or should I put that money to better use? I’m not asking for details on each just if any jump out as possible big winners. Thanks.
Q: With Mindmeds move from OTC in the USA to the Nasdaq does this change your feelings on this new potential bio space? Once listed on Nasdaq in your opinion does this give more validation to the company? Lastly would the shares on the NEO mirror the Nasdaq listing as it starts to trade?